The Patent Finder

Deuterated Compounds

Cybin UK Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,773,062Deuterated Compounds
In force
 · High confidence
Cybin UK Ltd.In force
High confidence
US 12,042,564Therapeutic Solid Dosage Forms
In force
 · High confidence
Cybin UK Ltd.In force
High confidence
US 12,521,370Inhalable Formulations
In force
 · Medium confidence
Cybin UK Ltd.In force
Medium confidence
Application 17/108,679Parenteral Formulation
Abandoned
Abandoned May 11, 2023
Cybin UK Ltd.AbandonedAbandoned May 11, 2023
Application 18/748,483Therapeutic Solid Dosage Forms
Pending
Not granted
Cybin UK Ltd.PendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Cybin UK Ltd..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited